Figure 2
From: Hepatitis C virus and non-Hodgkin's lymphoma: findings from the Swiss HIV Cohort Study
Comparison of percent distribution of CD4+ counts at NHL diagnosis (A) and NHL subtype (B) between 100 anti-HCV+ and 198 anti-HCV− NHL cases. Swiss HIV Cohort Study, 1984–2004. Anti-HCV: antibodies against hepatitis C virus; PBL: Primary brain lymphoma; DLBC: diffuse large B-cell NHL. ‘Unknown’ refers to no CD4+ count result within 6 months before cancer diagnosis.
